Introduction Thyroid cancer is the most common cancer of the endocrine system, with a continuously increasing incidence in the last decades ( Pellegriti et al. 2013 ). Papillary thyroid carcinoma is the most prevalent histologic type
T U Kars, M Kulaksızoğlu, and İ Kılınç
Vineeth Sukrithan, Prachi Jain, Manisha H Shah, and Bhavana Konda
Introduction Differentiated thyroid cancers (DTCs) represent the most common type of thyroid cancers (85%), followed by medullary thyroid cancers (MTCs) and anaplastic thyroid cancers (ATCs), representing 2 to 8% and 1%, respectively ( Porter
Patrick W Owens, Terri Patricia McVeigh, Nicola Miller, Carole Guerin, Frederic Sebag, Denis Quill, Marcia Bell, Michael J Kerin, and Aoife J Lowery
Introduction Thyroid cancer is the most common endocrine malignancy with an increasing incidence recorded over recent decades in Western countries, including Ireland. Genetic factors play a significant role in the determination of thyroid
Krishna Vikneson, Tariq Haniff, May Thwin, Ahmad Aniss, Alex Papachristos, Mark Sywak, and Anthony Glover
Introduction Well-differentiated thyroid cancer (DTC) and papillary thyroid cancer (PTC) incidence has been increasing in comparison to other thyroid cancers ( Davies & Welch 2014 , Davies & Hoang 2021 ). However, most thyroid cancer
Macarena Contreras Angulo, Belén García Izquierdo, Laura Armengod Grao, and Nuria Palacios García
, Nakashima et al. 2022 ). Although advanced neoplasm could be a potential cause of systemic TMA in our case, we consider it unlikely as no cases have been described associated with thyroid cancer in the absence of other recognized etiologic factors
Benjamin J Worrall, Alexander Papachristos, Ahmad Aniss, Anthony Glover, Stan B Sidhu, Roderick J Clifton-Bligh, Diana Learoyd, Venessa H M Tsang, Matti Gild, Bruce G Robinson, and Mark S Sywak
Introduction Papillary thyroid carcinoma (PTC) is the most common subtype of differentiated thyroid cancer, which comprises over 90% of all thyroid cancers ( Sherman 2003 , Haugen 2016 ). PTC has the best prognosis of all thyroid cancer
Sandra Pekic, Marko Stojanovic, and Vera Popovic
et al. 2014 , Terzolo et al. 2017 , Esposito et al. 2018 , 2021 ). Large epidemiological and observational studies on all cancers, colorectal cancer and thyroid cancers show inconsistent results ( Orme et al. 1998 , Jenkins & Besser 2001
Christie G Turin, Molly M Crenshaw, and Lauren Fishbein
2A: Medullary thyroid cancer, pheochromocytoma, primary hyperparathyroidism MEN2B: Medullary thyroid cancer, pheochromocytoma, mucosal neuromas MEN 2A: Calcitonin at 3–5 years old or prophylactic thyroidectomy. Calcium and PTH at 8 years old or 20
